Metraipolis › archive › dc_7e73b169bebc

An in silico VAR2CSA-based multi-epitope vaccine candidate (PM-MEV-k1) shows favourable Structural and Immune Simulation parameters for protection against… — Europe PMC PPR:PPR1323029

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR1323029
DOI
10.21203/rs.3.rs-10820730/v1
License (as archived)
solo-consultazione
Archived
2026-10-07T14:51:49.513Z
SHA-256 of the archived text
e1303848c24dd30aab16c6354a2c6c4db632288d5bc2c3b41b683165a513dd66
Stable URL of this page
https://metraipolis.com/documento/dc_7e73b169bebc

How to cite

An in silico VAR2CSA-based multi-epitope vaccine candidate (PM-MEV-k1) shows favourable Structural and Immune Simulation parameters for protection against… — Europe PMC PPR:PPR1323029 — Europe PMC, https://europepmc.org/article/PPR/PPR1323029 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e73b169bebc (Metraipolis archive dc_7e73b169bebc, sha256 e1303848c24dd30aab16c6354a2c6c4db632288d5bc2c3b41b683165a513dd66)
BibTeX
@misc{dc7e73b169bebc,
  title = {An in silico VAR2CSA-based multi-epitope vaccine candidate (PM-MEV-k1) shows favourable Structural and Immune Simulation parameters for protection against… — Europe PMC PPR:PPR1323029},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR1323029},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e73b169bebc; sha256 e1303848c24dd30aab16c6354a2c6c4db632288d5bc2c3b41b683165a513dd66},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR1323029. Agents can read the archived copy with the MCP tool read_document.